1. 1198PSerum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario. (23rd October 2018) Authors: Iacono, D; Vitale, M G; Cortiula, F; Cinausero, M; Tullio, A; Valent, F; Macerelli, M; Follador, A; Vogrig, A; Minisini, A M; Puglisi, F; Fasola, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. E25First-line platinum-based chemotherapy in elderly patients with NSCLC: determinants of therapeutic choice and outcome. (6th November 2017) Authors: Pelizzari, G; Gerratana, L; Cattaneo, M; Cortiula, F; Lisanti, C; Bartoletti, M; Giavarra, M; Buoro, V; De Carlo, E; Macerelli, M; Poletto, E; Rossetto, C; Rizzato, S; Puglisi, F; Fasola, G Journal: Annals of oncology Issue: Volume 28(2017)Supplement 6 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Relevance of BRAF and extended RAS mutational analyses for metastatic colorectal cancer patients. Issue 1 (2013) Authors: Aprile, G; Macerelli, M; Maglio, G De; Pizzolitto, S; Fasola, G Journal: OA molecular oncology Issue: Volume 1:Issue 1(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗